Literature DB >> 21437081

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?

Sergio Parco1.   

Abstract

Recent observations suggest the presence of an interaction between leptin and the inflammatory system during bronchial asthma. Although there is evidence of a positive association between asthma and obesity in adults and children, little is yet known about the role of serum leptin, as a potential mediator for bronchial epithelial homeostasis, and intraleukocyte myeloperoxidase (MPO), a hemoprotein with a molecular weight of 140 kDa, expression of the inflammatory system, in asthmatic children. Glycemic tolerance is an important pathogenetic element in developing type 2 mellitus diabetes and a confirmed predictor of incident asthma-like symptoms in adults. This work is aimed at assessing a possible correlation between basal leukocyte myeloperoxidase levels, basal leptin and insulin-glycemic tolerance in obese children. Thirty obese children aged between 7 and 15 years were examined. The analyzed data showed a normal response to the insulinemic stimulus in children of both sexes whose basal leptin and MPO values, expressed as MPO intracellular index, were within the normal range.

Entities:  

Keywords:  asthma; glycemic tolerance; leptin; myeloperoxidase

Year:  2010        PMID: 21437081      PMCID: PMC3047972          DOI: 10.2147/dmsott.s8504

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


Background

Recent observations suggest the presence of an interaction between leptin and the inflammatory system during bronchial asthma.1,2 Leptin, the hormone mainly synthesized by adipose tissue, is involved in a complex network of neurotrasmitters that modulate appetite. Many tissues produce leptin: the placenta syncytial trophoblast, the gastric fundus mucosa, skeletal muscle tissue and hypophysis. Most of leptin, however, is produced in adipose tissue. Leptin’s role is mainly to regulate food intake, but it also has a number of other metabolic functions: it stimulates macrophages and neutrophils, it has an antiapoptotic activity on various cell types, and it regulates T-cell proliferation. The production/suppression of leptin plasma levels is mainly related to the quantity of adipocytes, but also to various endocrinological factors, the main one being insulin levels. The lower the insulin levels, the lower the leptin synthesis. Low insulin levels are in fact typical indicators of hunger. Other factors that stimulate leptin secretion are: adrenergic stimuli, growth hormone (GH) and thyroid hormones such as triiodothyronine and inflammatory stimuli. The leptin-producing obese (OB) gene is located on chromosome 7 and has three exons and two introns. The OB gene transcription can be regulated by response elements, such as sequences of nucleotides to which transcription factors bind (such as the cAMP Response Element [CRE]).3–5 Recent observations suggest the presence of an interaction between leptin and the inflammatory system. However, there is no adequate knowledge about the role of leptin in atopic states, such as bronchial asthma.2 Although there is evidence of a positive association between asthma and obesity in adults and children, little is yet known about the role of leptin in asthmatic children: the findings suggest that leptin may play a role in atopic asthma, prevailing in postadolescent male children and in asthmatic boys. Insulin resistance (IR) is a confirmed predictor of incident asthma-like symptoms in adults and leptin is potentially a mediator for bronchial epithelial homeostasis: decreased expression of leptin/leptin receptor characterizes severe asthma and is associated with airway remodelling features.6–9 Myeloperoxidase (MPO) is a hemoprotein with a molecular weight of 140 kDa, and is made of two light subunits weighing 15 kDa. Each MPO molecule contains two porphyrins that play a fundamental role in the catalytic cycle. MPO is firstly found in the grains of neutrophils and eosinophils. It has a bactericidal potential since it catalyzes the production of hypochlorous acid, a potent oxidant generated by the reaction of chloride ion with hydrogen peroxide, which has a significant pro-inflammatory action and contributes directly to tissue damage. The expression of leptin receptors on eosinophils has recently shown that leptin can be considered a survival cytokine for human neutrophils and eosinophils and has a relevant potential role to play in allergic and inflammatory diseases.

Study aim

This work aims to verify through a retrospective study, the following personal observations: whether the relationship between obesity and asthma are mediated by an inflammatory state as measured by elevated leptin and leukocyte MPO levels in obese children, and by studying glycemic tolerance, which is an early sign of diabetes mellitus and associated IR.

Methods

Thirty obese children (15 males and 15 females with body mass index [BMI] > 30), without bronchial asthma symptoms, aged between 7 and 15 years were examined. Informed consent was obtained according to the criteria of the Helsinki Treaty. Glucose tolerance in these patients was analyzed by providing them with a stimulus: they were administered 1.75 g of glucose/Kg and the response was assessed at times 0, 60, and 120 min. Leptin was evaluated using ELISA – Technogenetics (Milan, Italy). MPO of neutrophil and eosinophil counts were analyzed with ADVIA 120 automated analyzer as myeloperoxidase intracellular index (MPXI), a parameter derived from the mean position on the axis of an archetypal population of neutrophils and eosinophils: cells absorb light in proportion to the amount of colored peroxidase that is present (reported on x-axis) and spread light in proportion to their size (reported on y-axis). This whole blood automated method is certified and developed to assess eosinophil and neutrophil activity in terms of peroxidase content and cell morphology. All subjects had an MPXI greater than −10 to ensure that no case of MPO deficiency was included. The level of C-reactive protein (CRP) as an inflammation index was determined in all the patients and control tests on thyroid functionality, were performed by Modular P1 – Roche (Geneva, Switzerland) to exclude other simultaneous correlated pathologies (Tables 1 and 2). The BMI values for the children aged 7–15 years were 31.4 ± 2.7 kg/m?.
Table 1

Biochemical test values and MPXI values in normal response

CRP0.0 ± 0.4(n.v. 0.0–0.5 mg%)
fT33.2 ± 1.1(n.v. 1.62–5.52 pg/mL)
fT41.3 ± 0–9(n.v. 0.74–2.04 ng/mL)
TSH2.9 ± 0.5(n.v. 0.25–4.6 mU/L)
Leptin7.6 ± 3.1(n.v. 1.64–13.32 mg%)
MPXI4 ± 2.0(n.v. −10 + 10)

Abbreviations: CRP, C-reactive protein; fT, free thyroxine; MPXI, intracellular mean peroxidase index; TSH, thyroid-stimulating hormone.

Table 2

Biochemical test and MPXI values in pathological response

CRP0.0 ± 0.4(n.v. 0.0–0.5 mg%)
fT32.3 ± 1.0(n.v. 1.62–5.52 pg/mL)
fT41.7 ± 0.6(n.v. 0.74–2.04 ng/dL)
TSH3.4 ± 0.6(n.v. 0.25–4.6 mU/L)
Leptin16.3 ± 4.5(n.v. 1.64–13.32 mg%)
MPXI12 ± 7(n.v. −10 + 10)

Abbreviations: CRP, C-reactive protein; fT, free thyeroxine; MPXI, intracellular mean peroxidase index; TSH, thyroid-stimulating hormone.

Results

The analyzed data showed a normal response to the insulinemic stimulus in children of both sexes whose basal leptin and MPXI values were within the normal range. (Figures 1 and 2). Pathological stimulus-related values were correlated to high basal leptin and MPXI levels (Figures 3 and 4). MPXI and leptin are directly correlated one with the other (P < 0.001). The CRP results and other main thyroid tests were in the normal range.
Figure 1

Glucose (mg%) and insulin levels (μUI/mL) after oral glucose tolerance test in normal response.

Figure 2

Insulin levels (μUI/mL) after oral glucose tolerance test in normal response.

Figure 3

Glucose (mg%) after oral glucose tolerance test in pathological response.

Figure 4

Insulin levels (μUI/mL) after oral glucose tolerance test in pathological response.

Discussion

MPXI for subjects of the same group of age, without asthma symptoms, but with obesity and normal range of basal glucose, are defined in the literature.16,17 Many evidences show a correlation between obesity and increased risk of bronchial asthma. Altered GT and IR are believed to play an significant role in asthma, although precise data are not available.10–15 IR is, after all, a common condition in many multifactorial diseases such as obesity and type 2 diabetes. The presence of a common inflammatory factor may explain the relationship between GT, IR, and asthma. Leptin is known to be one of these factors. A high MPXI could be another contributing factor that may have to be assessed when directly correlated with leptin. Our experience has shown that high MPO and leptin levels are indicative of an altered response to the glucose and IR load. Our work is aimed at proposing the determination of leukocyte MPXI when analyzing basal leptin and serum glucose. This test is included in the hemochrome-cytometric exam and does not entail any extra costs. Associated high levels of MPXI and leptin in obese children may suggest an altered response to the oral glucose load and to be prediction of asthma.
  17 in total

1.  Resting metabolic rate, body-fat distribution, and visceral fat in obese women.

Authors:  F Armellini; R Robbi; M Zamboni; T Todesco; S Castelli; O Bosello
Journal:  Am J Clin Nutr       Date:  1992-12       Impact factor: 7.045

Review 2.  The role of fat cell derived peptides in age-related metabolic alterations.

Authors:  I Gabriely; N Barzilai
Journal:  Mech Ageing Dev       Date:  2001-09-30       Impact factor: 5.432

3.  Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients.

Authors:  M J Leckie; S A Bryan; J Khan; A Dewar; S L Aikman; J McGrath; D A Okrongly; J F Burman; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

4.  Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma.

Authors:  T Fujisawa; A Terada; J Atsuta; K Iguchi; H Kamiya; M Sakurai
Journal:  Clin Exp Allergy       Date:  1998-01       Impact factor: 5.018

5.  Depot-specific differences in adipose tissue gene expression in lean and obese subjects.

Authors:  A M Lefebvre; M Laville; N Vega; J P Riou; L van Gaal; J Auwerx; H Vidal
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

Review 6.  The role of the novel adipocyte-derived hormone adiponectin in human disease.

Authors:  Juan J Díez; Pedro Iglesias
Journal:  Eur J Endocrinol       Date:  2003-03       Impact factor: 6.664

7.  Leptin: does it have any role in childhood asthma?

Authors:  Nermin Guler; Emel Kirerleri; Ulker Ones; Zeynep Tamay; Nihal Salmayenli; Feyza Darendeliler
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

8.  Adipocytokines, fat distribution, and insulin resistance in elderly men and women.

Authors:  Elena Zoico; Vincenzo Di Francesco; Gloria Mazzali; Roberto Vettor; Francesco Fantin; Luisa Bissoli; Silvia Guariento; Ottavio Bosello; Mauro Zamboni
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-09       Impact factor: 6.053

9.  Leptin and leptin receptor expression in asthma.

Authors:  Andreina Bruno; Elisabetta Pace; Pascal Chanez; Delphine Gras; Isabelle Vachier; Giuseppina Chiappara; Maurizio La Guardia; Stefania Gerbino; Mirella Profita; Mark Gjomarkaj
Journal:  J Allergy Clin Immunol       Date:  2009-06-21       Impact factor: 10.793

Review 10.  Minireview: adiposity, inflammation, and atherogenesis.

Authors:  Christopher J Lyon; Ronald E Law; Willa A Hsueh
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

View more
  1 in total

1.  Serum Myeloperoxidase as a Biomarker of Asthma Severity Among Adults: A Case Control Study.

Authors:  Shaymaa Obaid Abdullah; Ghazi Mohamad Ramadan; Hayder Abdul-Amir Makki Al-Hindy; Mazin Jaafar Mousa; Amir Al-Mumin; Safa Jihad; Suhad Hafidh; Yaqeen Kadhum
Journal:  Rep Biochem Mol Biol       Date:  2022-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.